A multimodal iPSC platform for cystic fibrosis drug testing
Hundreds of mutations in the gene CFTR lead to cystic fibrosis and represent a challenge to developing therapeutics. Here, authors demonstrate the ability of airway cells derived from human iPSCs to model genotype-specific CFTR function as well as pharmacologic rescue of disease causing mutations.
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Portfolio
2022-07-01
|
| Sarja: | Nature Communications |
| Linkit: | https://doi.org/10.1038/s41467-022-31854-8 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
